News | September 12, 2023
Indian pharma industry to witness 8-10% revenue growth in fiscal 2024: CRISIL
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
The products will be manufactured at the company's facility in Bengaluru
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Propranolol LA is a generic equivalent of Inderal LA
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
Pirfenidone Capsules had estimated annual sales of USD 95 million in the US
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
Subscribe To Our Newsletter & Stay Updated
